Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Mitsui, Hikari"'
Publikováno v:
In Sensors & Actuators: B. Chemical 2000 66(1):25-27
Autor:
Iida T; Cell Therapy Sciences, Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan; Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan. Electronic address: tomomine.iida@takeda.com., Nakamura Y; Cell Therapy Sciences, Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan. Electronic address: yoshiki.nakamura@takeda.com., Yamamoto K; Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan; Quality Control, Global Quality, Hikari Plant, Takeda Pharmaceutical Company Limited, 4720, Takeda, Mitsui, Hikari, Yamaguchi 743-8502, Japan. Electronic address: katsuhiko.yamamoto@takeda.com., Maeda E; Cell Therapy Sciences, Research, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan. Electronic address: eiki.maeda@takeda.com., Ikeda Y; Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan; Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-Chome, Fujisawa, Kanagawa 251-8555, Japan. Electronic address: yukihiro.ikeda@takeda.com.
Publikováno v:
Journal of virological methods [J Virol Methods] 2024 Nov 19; Vol. 332, pp. 115075. Date of Electronic Publication: 2024 Nov 19.
Autor:
Harada Y; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan; Department of Virology III, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan., Takahashi H; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan., Fujimoto T; BIKEN CO., Ltd., 4-1-70, Seto-Cho, Kan-Onji, Kagawa 768-0065, Japan., Horikoshi F; BIKEN CO., Ltd., 4-1-70, Seto-Cho, Kan-Onji, Kagawa 768-0065, Japan., Chida S; BIKEN CO., Ltd., 4-1-70, Seto-Cho, Kan-Onji, Kagawa 768-0065, Japan., Tanaka K; Daiichi Sankyo Biotech Co., Ltd., 6-111 Arai, Kitamoto City, Saitama Prefecture 364-0026, Japan., Minari K; Takeda Pharmaceutical Company Limited, Hikari Plant, 4720 Takeda, Mitsui, Hikari City, Yamaguchi 743-8502, Japan., Tanimoto Y; Takeda Pharmaceutical Company Limited, Hikari Plant, 4720 Takeda, Mitsui, Hikari City, Yamaguchi 743-8502, Japan., Fujisaki S; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan., Miura H; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan., Nakauchi M; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan., Shimasaki N; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan; Department of Virology III, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan., Suzuki Y; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan., Arita T; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan., Hamamoto I; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan., Yamamoto N; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan., Hasegawa H; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan., Odagiri T; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan., Tashiro M; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan., Nobusawa E; Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, 4-7-1, Gakuen, Musashi-murayama, Tokyo 208-0011, Japan. Electronic address: nobusawa@niid.go.jp.
Publikováno v:
Vaccine [Vaccine] 2024 Oct 03; Vol. 42 (23), pp. 126242. Date of Electronic Publication: 2024 Aug 29.
Preparation of Cubosomes with Improved Colloidal and Structural Stability Using a Gemini Surfactant.
Autor:
Nagao M; Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.; Japan Manufacturing, Global Vaccine Business Unit, Takeda Pharmaceutical Company, Limited, 4720 Takeda, Mitsui, Hikari 743-8502, Yamaguchi, Japan., Ranneh AH; Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company, Limited, 26-1, Muraoka-Higashi 2-Chome, Fujisawa 251-8555, Kanagawa, Japan., Iwao Y; Department of Physical Pharmaceutics, School of Pharmaceutical Sciences, Wakayama Medical University, 25-1 Shichiban-cho, Wakayama 640-8156, Japan., Yamamoto K; Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.; Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company, Limited, 26-1, Muraoka-Higashi 2-Chome, Fujisawa 251-8555, Kanagawa, Japan., Ikeda Y; Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.; Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company, Limited, 26-1, Muraoka-Higashi 2-Chome, Fujisawa 251-8555, Kanagawa, Japan.
Publikováno v:
Molecular pharmaceutics [Mol Pharm] 2023 Oct 02; Vol. 20 (10), pp. 5066-5077. Date of Electronic Publication: 2023 Sep 19.
Autor:
Higuchi S; Japan CMC, Vaccine Operations CMC, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi 743-8502, Japan., Satou T; Japan CMC, Vaccine Operations CMC, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi 743-8502, Japan., Uchida Y; Japan CMC, Vaccine Operations CMC, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi 743-8502, Japan.
Publikováno v:
MethodsX [MethodsX] 2023 Mar 11; Vol. 10, pp. 102126. Date of Electronic Publication: 2023 Mar 11 (Print Publication: 2023).
Autor:
Torisu T; Vaccine Operations, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi 743-0011, Japan. Electronic address: tetsuo.torisu@bio.eng.osaka-u.ac.jp., Shikama S; Vaccine Operations, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi 743-0011, Japan., Nakamura K; Vaccine Operations, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi 743-0011, Japan., Enomoto K; Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan., Maruno T; Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan., Mori A; Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan., Uchiyama S; Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan., Satou T; Vaccine Operations, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi 743-0011, Japan.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2021 May; Vol. 110 (5), pp. 2121-2129. Date of Electronic Publication: 2020 Dec 17.
Autor:
Ogasawara N; Japan CMC, Product Operations, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi, 743-8502, Japan. Electronic address: nao.ogasawara@takeda.com., Misaki M; Japan CMC, Product Operations, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi, 743-8502, Japan., Adachi S; Japan CMC, Product Operations, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi, 743-8502, Japan.
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization [Biologicals] 2019 Mar; Vol. 58, pp. 73-75. Date of Electronic Publication: 2019 Jan 17.
Autor:
Kiyoshi M; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan., Shibata H; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan. Electronic address: h-shibata@nihs.go.jp., Harazono A; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan., Torisu T; Vaccine Operations, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi 743-0011, Japan., Maruno T; U-Medico Inc., 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan., Akimaru M; Analytical and Quality Evaluation Research Laboratories, Daiichi Sankyo Co., Ltd., 1-12-1, Shinomiya, Hiratsuka, Kanagawa 254-0014, Japan., Asano Y; Research Division, Formulation Development, Biomanufacturing Technology, JCR Pharmaceuticals Co., Ltd., 2-2-9 Murotani, Nishi-ku, Kobe, Hyogo 651-2241, Japan., Hirokawa M; Supply Chain Management Division, Pharmaceutical Research Department, Production Technology, Mitsubishi Tanabe Pharma Corporation, 3-16-89, Kashima, Yodogawa-ku, Osaka-shi, Osaka 532-8505, Japan., Ikemoto K; Supply Chain Management Division, Pharmaceutical Research Department, Production Technology, Mitsubishi Tanabe Pharma Corporation, 3-16-89, Kashima, Yodogawa-ku, Osaka-shi, Osaka 532-8505, Japan., Itakura Y; Biologics and New Modalities Development, Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 4720 Takeda, Mitsui, Hikari, Yamaguchi 743-0011, Japan., Iwura T; Bio Process Research and Development Laboratories, Kyowa Hakko Kirin Co., Ltd., 100-1, Hagiwara-machi, Takasaki, Gunma 370-0013, Japan., Kikitsu A; Pharmaceutical Research Laboratories, Nippon Kayaku Co., Ltd., 3-31-12, Shimo, Kita-ku, Tokyo 115-0042, Japan., Kumagai T; Pharmaceutical Science and Technology Labs, Pharmaceutical Technology, Astellas Pharma Inc., 2-5-3 Tokodai, Tsukuba, Ibaraki 300-2698, Japan., Mori N; Supply Chain Management Division, Pharmaceutical Research Department, Production Technology, Mitsubishi Tanabe Pharma Corporation, 3-16-89, Kashima, Yodogawa-ku, Osaka-shi, Osaka 532-8505, Japan., Murase H; Research Division, Formulation Development, Biomanufacturing Technology, JCR Pharmaceuticals Co., Ltd., 2-2-9 Murotani, Nishi-ku, Kobe, Hyogo 651-2241, Japan., Nishimura H; Pharmaceutical Laboratory, Mochida Pharmaceutical Co., Ltd., 342 Gensuke, Fujieda, Shizuoka 426-8640, Japan., Oda A; CMC Regulatory and Analytical R&D, Ono Pharmaceutical Co., Ltd., 1-1, Sakurai 3-chome, Shimamoto-cho, Mishima-gun, Osaka 618-8585, Japan., Ogawa T; CMC Analysis Laboratory, Toray Research Center, Inc., 9-1, Oe-cho, Minato-ku, Nagoya, Aichi 455-8502, Japan., Ojima T; Analytical and Quality Evaluation Research Laboratories, Daiichi Sankyo Co., Ltd., 1-12-1, Shinomiya, Hiratsuka, Kanagawa 254-0014, Japan., Okabe S; Research Division, Formulation Development, Biomanufacturing Technology, JCR Pharmaceuticals Co., Ltd., 2-2-9 Murotani, Nishi-ku, Kobe, Hyogo 651-2241, Japan., Saito S; Analytical and Quality Evaluation Research Laboratories, Daiichi Sankyo Co., Ltd., 1-12-1, Shinomiya, Hiratsuka, Kanagawa 254-0014, Japan., Saitoh S; Pharmaceutical Technology Division, Quality Development Department, Chugai Pharma Manufacturing, 5-1, Ukima, 5-chome, Kita-ku, Tokyo 115-8543, Japan., Suetomo H; Bio Process Research and Development Laboratories, Kyowa Hakko Kirin Co., Ltd., 100-1, Hagiwara-machi, Takasaki, Gunma 370-0013, Japan., Takegami K; CMC Analysis Laboratory, Toray Research Center, Inc., 9-1, Oe-cho, Minato-ku, Nagoya, Aichi 455-8502, Japan., Takeuchi M; Pharmaceutical Research Laboratories, Nippon Kayaku Co., Ltd., 3-31-12, Shimo, Kita-ku, Tokyo 115-0042, Japan., Yasukawa H; Research Division, Formulation Development, Biomanufacturing Technology, JCR Pharmaceuticals Co., Ltd., 2-2-9 Murotani, Nishi-ku, Kobe, Hyogo 651-2241, Japan., Uchiyama S; Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan., Ishii-Watabe A; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 3-25-26, Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-9501, Japan.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2019 Feb; Vol. 108 (2), pp. 832-841. Date of Electronic Publication: 2018 Aug 16.
Autor:
Harazono A; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Tonomachi 3-25-26, Kawasaki-ku, Kanagawa, 210-9501, Japan. Electronic address: harazono@nihs.go.jp., Shibata H; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Tonomachi 3-25-26, Kawasaki-ku, Kanagawa, 210-9501, Japan., Kiyoshi M; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Tonomachi 3-25-26, Kawasaki-ku, Kanagawa, 210-9501, Japan., Muto T; Biotechnology Labs., Pharmaceutical Technology, Astellas Pharma Inc., 5-2-3, Tokodai, Tsukuba-shi, Ibaraki, 300-2698, Japan., Fukuda J; Product Strategy Group, Corporate Strategy and Planning Department, Kyowa Hakko Kirin Co., Ltd, Otemachi Financial City Grand Cube, 1-9-2, Otemachi, Chiyoda-ku, Tokyo, 100-0004, Japan., Torisu T; Product Operations, Global Vaccine Business Unit, Takeda Pharmaceutical Company Limited, 4720, Takeda, Mitsui, Hikari, Yamaguchi, 743-0011, Japan., Saitoh S; Quality Development Dept., Pharmaceutical Technology Div., Chugai Pharma Manufacturing Co., Ltd., 5-1, Ukima, 5-chome, Kita-ku, Tokyo, 115-8543, Japan., Nishimura H; Pharmaceutical Laboratory, Mochida Pharmaceutical Co., Ltd, 342 Gensuke, Fujieda, Shizuoka, 426-8640, Japan., Uchiyama S; U-Medico Inc., 2-1 Yamadaoka, Suita, Osaka, 565-0871, Japan; Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka, 565-0871, Japan., Ishii-Watabe A; Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, Tonomachi 3-25-26, Kawasaki-ku, Kanagawa, 210-9501, Japan.
Publikováno v:
Biologicals : journal of the International Association of Biological Standardization [Biologicals] 2019 Jan; Vol. 57, pp. 46-49. Date of Electronic Publication: 2018 Dec 13.
Autor:
Kuwae S; Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 26-1, Muraoka-Higashi 2-chome, Fujisawa, Kanagawa, 251-8555, Japan. shinobu.kuwae@takeda.com., Miyakawa I; Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 4720, Takeda Mitsui, Hikari, Yamaguchi, 743-8502, Japan., Doi T; Pharmaceutical Sciences, Takeda Pharmaceutical Company Limited, 4720, Takeda Mitsui, Hikari, Yamaguchi, 743-8502, Japan.
Publikováno v:
Cytotechnology [Cytotechnology] 2018 Jun; Vol. 70 (3), pp. 939-948. Date of Electronic Publication: 2018 Jan 11.